Advances in Purinergic Signaling Research: From Molecular Biology to Human Diseases
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 178
Special Issue Editor
2. CIBB—Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3000-548 Coimbra, Portugal
Interests: role of purinergic receptors in brain development and disease
Special Issue Information
Dear Colleagues,
Purinergic signaling is an ancient extracellular signaling system. Accordingly, purinergic signaling components, both purinergic receptors and ecto-enzymes controlling extracellular metabolism of purines, as well as active mechanisms of purine release, are ubiquitous, being identified in multiple tissues and cells, fulfilling a wide array of physiological functions across ontogeny, from early embryogenesis to aging. Such ubiquitous expression of purinergic signaling in virtually all systems throughout life places this signaling system at a central stage in health and disease.
This Special Issue is designed to gather relevant contributions, both original research articles and reviews, providing or reviewing the most recent advances in the molecular biology, physiology, and pathophysiology of purinergic signaling from development to aging. I look forward to receiving your contributions.
Dr. Ricardo Rodrigues
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ATP
- adenosine
- P1 receptors
- P2 receptors
- P2X receptors
- P2Y receptors
- ecto-nucleotidases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
